Replies to post #81559 on Biotech Values

[DewDiligence]

MS Drugs: 2Q09 US Market Share

 
         Sales Market 
           $M  Share  
 Copaxone 438   38% 
 Avonex   366   32% 
 Rebif    198   17% 
 Tysabri  125   11% 
 Other     22    2% 
 =====  =====  ==== 
 Total  1,149  100% 

Copaxone, Avonex, and Tysabri sales are as reported
by Teva and Biogen Idec; Rebif sales are estimated
from Merck KGaA and PFE financial statements.